Jupiter Life Line Hospitals: ₹194 Cr profit, 1:5 stock split approved

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorIshaan Verma|Published at:
Jupiter Life Line Hospitals: ₹194 Cr profit, 1:5 stock split approved
Overview

Jupiter Life Line Hospitals posted audited FY26 results, with a ₹194.19 crore net profit on revenues over ₹1,542.16 crore. The company's board approved a 10% interim dividend and a 1:5 stock split to improve share liquidity and affordability.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Financial Results for FY26

Jupiter Life Line Hospitals Ltd. has reported its audited financial results for the fiscal year ending March 31, 2026. The company announced a consolidated net profit of ₹194.19 crore, on consolidated total income amounting to ₹1,542.16 crore. For standalone operations, revenue from operations reached ₹1,197.62 crore, yielding a net profit of ₹191.38 crore.

Shareholder Actions: Dividend and Stock Split

In addition to financial results, the Board of Directors approved a 10% interim dividend. This translates to ₹1 per equity share, with the record date set for May 22, 2026.

The board also sanctioned a 1:5 stock split. This means each equity share with a face value of ₹10 will be divided into five shares of ₹2 each. This move is intended to boost market liquidity and make shares more affordable for a wider range of investors.

Leadership Confirmation

Key leadership roles were also confirmed, with Dr. Ajay Thakker appointed as Chairman & Whole Time Director.

Operational Context

Jupiter Life Line Hospitals operates as a prominent multi-specialty hospital chain across India. The company manages five hospitals in key cities including Thane, Navi Mumbai, Indore, and Nagpur, with a focus on advanced tertiary and quaternary care. The company successfully conducted its Initial Public Offering (IPO) in September 2023, using the raised capital for expansion and working capital needs.

Impact on Investors

Following these approvals, shareholders will receive the interim dividend payment. The stock split will significantly increase the number of shares held by investors. For example, holding 100 shares will result in owning 500 shares, while the face value per share decreases from ₹10 to ₹2. This is expected to enhance liquidity and broaden investor access to the company's stock.

Market and Financial Metrics

For FY26, Jupiter Life Line Hospitals achieved a consolidated net profit margin of 12.59%. The standalone net profit margin was 15.98%. This represents growth from the previous fiscal year, where consolidated net profit stood at ₹130 crore in FY25.

Competitive Landscape

The hospital sector is highly competitive, with players such as Apollo Hospitals, Fortis Healthcare, Max Healthcare, and Narayana Hrudayalaya. Jupiter Life Line Hospitals operates within this dynamic environment, characterized by strong demand for quality healthcare services and continuous expansion.

No Immediate Risks Noted

The company's filing for this announcement did not explicitly detail any specific risks or negative factors.

Looking Ahead

Investors will be watching for the official announcement of the Annual General Meeting (AGM) date. Shareholder approval will be required for the proposed stock sub-division. Future focus will also be on the company's expansion plans, capacity utilization, and its performance relative to its peers.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.